Premium
Alzheimer’s amyloid peptides mediate hypoxic up‐regulation of L‐type Ca 2+ channels
Author(s) -
Scragg Jason L.,
Fearon Ian M.,
Boyle John P.,
Ball Stephen G.,
Varadi Gyula,
Peers Chris
Publication year - 2005
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fj.04-2659fje
Subject(s) - extracellular , hek 293 cells , patch clamp , protein subunit , immunoprecipitation , chemistry , amyloid precursor protein , amyloid precursor protein secretase , microbiology and biotechnology , alzheimer's disease , pharmacology , biochemistry , biology , medicine , receptor , disease , gene
We examined the effects of chronic hypoxia on recombinant human L‐type Ca 2+ channel α 1C subunits stably expressed in HEK 293 cells, using whole‐cell patch‐clamp recordings. Current density was dramatically increased following 24 h exposure to chronic hypoxia (CH), and membrane channel protein levels were enhanced. CH also increased the levels of Alzheimer's amyloid β peptides (AβPs), determined immunocytochemically. Pharmacological prevention of AβP production (via exposure to inhibitors of secretase enzymes that are required to cleave AβP from its precursor protein) prevented hypoxic augmentation of currents, as did inhibition of vesicular trafficking with bafilomycin A1. The enhancing effect of AβPs or CH were abolished following incubation with the monoclonal 3D6 antibody, raised against the extracellular N′ terminus of AβP. Immunolocalization and immunoprecipitation studies provided compelling evidence that AβPs physically associated with the α 1C subunit, and this association was promoted by hypoxia. These data suggest an important role for AβPs in mediating the increase in Ca 2+ channel activity following CH and show that AβPs act post‐transcriptionally to promote α 1C subunit insertion into (and/or retention within) the plasma membrane. Such an action will likely contribute to the Ca 2+ dyshomeostasis of Alzheimer's disease and may contribute to the mechanisms underlying the known increased incidence of this neurodegenerative disease following hypoxic episodes.